- 46
- 136 126
Australian Psychedelic Society
Australia
Приєднався 28 лип 2017
The Australian Psychedelic Society (APS) is a grassroots community-based organisation that firmly believes in the decriminalisation and safe use of psychedelics.
A large body of our work involves advocacy and changing narratives surrounding psychedelics. This includes raising awareness and educating our community, leaders, physicians (and everyone in between) on the potential health benefits, risks and outcomes when using these medicines, regardless of whether it be recreational use, for mental health, physical health, spiritual development, consciousness exploration or other reasons.
We hope that in creating communities across Australia we can better advocate for the decriminalisation of psychedelics and break stigmas associated with their use.
A large body of our work involves advocacy and changing narratives surrounding psychedelics. This includes raising awareness and educating our community, leaders, physicians (and everyone in between) on the potential health benefits, risks and outcomes when using these medicines, regardless of whether it be recreational use, for mental health, physical health, spiritual development, consciousness exploration or other reasons.
We hope that in creating communities across Australia we can better advocate for the decriminalisation of psychedelics and break stigmas associated with their use.
DOSED2: The Trip of A Lifetime Q&A panel, Sydney, 23–04-2023
This Q&A panel was recorded at the premiere screening of DOSED2 at Dendy, Newtown with guest speakers; Jonathan Brett, Steve Albert & Vince Polito and hosted by APS’ Jef Baker.
Jonathan Brett
Dr Jonathan Brett is a senior staff specialist in clinical toxicology and addiction medicine at St. Vincent’s Hospital, Sydney, clinical director of the Psychiatry and Non-Prescription Drug and Alcohol Unit and a clinical toxicologist with the NSW Poison’s Information Centre.
He has fellowships with the Royal Australian College of Physicians in clinical pharmacology, toxicology and addiction medicine. He is a conjoint Associate Professor with St. Vincent’s Clinical School, UNSW and a Senior NHMRC Research Fellow with the Medicines Policy Unit of Centre for Big Data Research in Health, UNSW. He is the chief investigator on a pilot study of psilocybin facilitated psychotherapy (PP) for methamphetamine use disorder (MAUD), the first PP study of addiction in Australia and the first for MAUD worldwide. He is also the chief investigator on a trial of PP for treatment resistant depression and chief medical advisor for a study of psilocybin microdosing for depression. He completed his PhD in biostatistics in 2018 with a focus on the use of big data measure the quality use of psychotropics in mental health and has a research interest in psychopharmacology.
Vince Polito
Dr Vince Polito is a Senior Lecturer from the School of Psychological Sciences at Macquarie University and had won awards for his work as well as published 44 journal articles and numerous features in popular press.
Vince has a keen interest in understanding how altered states of consciousness can impact on cognition and mental health, and he and his students have studied hypnosis, states of flow, meditation, yoga, chanting, virtual reality, religious rituals and psychosis.
Vince is best known for his work in psychedelics, conducting the first longitudinal study of microdosing, which has become the most cited paper on the subject to date. He is developing a psychedelic research program at Macquarie that includes the world’s first magnetoencephalography (MEG) study of microdosing, and is leading Australia’s largest psychedelic clinical trial, which will investigate low doses of psilocybin as a potential treatment for depression.
Steve Albert
Steve Albert is a psychologist in private practice, adjunct senior lecturer at UNSW School of Psychiatry, Faculty of Medicine University of NSW and casual lecturer at Department of Psychology Faculty of Medicine, Health and Human Sciences Macquarie University and Honorary Research Investigator at St Vincent’s Hospital Sydney.
His therapeutic orientation includes acceptance and commitment therapies, treatments for PTSD, psychodynamic parts-based therapies and humanistic and transpersonal psychotherapeutic approaches.
His Psychedelic Assisted Psychotherapy research roles include:
• Research investigator and lead therapist, and trainer in two psilocybin psychedelic assisted psychotherapy (PAP) clinical trials being held at St Vincent’s hospital in Sydney (One for methamphetamine abuse disorder and one for treatment resistant depression).
*Multidisciplinary Association of Psychedelic Studies (MAPS) trained therapist in upcoming Monash, Clinical Psychedelic Lab’s clinical trials using MDMA-assisted psychotherapy for severe PTSD.
*Training assistant in the upcoming Australian MAPS delivered MDMA-assisted Therapist Training Program in collaboration with the Clinical Psychedelic Lab at Monash University.
Jonathan Brett
Dr Jonathan Brett is a senior staff specialist in clinical toxicology and addiction medicine at St. Vincent’s Hospital, Sydney, clinical director of the Psychiatry and Non-Prescription Drug and Alcohol Unit and a clinical toxicologist with the NSW Poison’s Information Centre.
He has fellowships with the Royal Australian College of Physicians in clinical pharmacology, toxicology and addiction medicine. He is a conjoint Associate Professor with St. Vincent’s Clinical School, UNSW and a Senior NHMRC Research Fellow with the Medicines Policy Unit of Centre for Big Data Research in Health, UNSW. He is the chief investigator on a pilot study of psilocybin facilitated psychotherapy (PP) for methamphetamine use disorder (MAUD), the first PP study of addiction in Australia and the first for MAUD worldwide. He is also the chief investigator on a trial of PP for treatment resistant depression and chief medical advisor for a study of psilocybin microdosing for depression. He completed his PhD in biostatistics in 2018 with a focus on the use of big data measure the quality use of psychotropics in mental health and has a research interest in psychopharmacology.
Vince Polito
Dr Vince Polito is a Senior Lecturer from the School of Psychological Sciences at Macquarie University and had won awards for his work as well as published 44 journal articles and numerous features in popular press.
Vince has a keen interest in understanding how altered states of consciousness can impact on cognition and mental health, and he and his students have studied hypnosis, states of flow, meditation, yoga, chanting, virtual reality, religious rituals and psychosis.
Vince is best known for his work in psychedelics, conducting the first longitudinal study of microdosing, which has become the most cited paper on the subject to date. He is developing a psychedelic research program at Macquarie that includes the world’s first magnetoencephalography (MEG) study of microdosing, and is leading Australia’s largest psychedelic clinical trial, which will investigate low doses of psilocybin as a potential treatment for depression.
Steve Albert
Steve Albert is a psychologist in private practice, adjunct senior lecturer at UNSW School of Psychiatry, Faculty of Medicine University of NSW and casual lecturer at Department of Psychology Faculty of Medicine, Health and Human Sciences Macquarie University and Honorary Research Investigator at St Vincent’s Hospital Sydney.
His therapeutic orientation includes acceptance and commitment therapies, treatments for PTSD, psychodynamic parts-based therapies and humanistic and transpersonal psychotherapeutic approaches.
His Psychedelic Assisted Psychotherapy research roles include:
• Research investigator and lead therapist, and trainer in two psilocybin psychedelic assisted psychotherapy (PAP) clinical trials being held at St Vincent’s hospital in Sydney (One for methamphetamine abuse disorder and one for treatment resistant depression).
*Multidisciplinary Association of Psychedelic Studies (MAPS) trained therapist in upcoming Monash, Clinical Psychedelic Lab’s clinical trials using MDMA-assisted psychotherapy for severe PTSD.
*Training assistant in the upcoming Australian MAPS delivered MDMA-assisted Therapist Training Program in collaboration with the Clinical Psychedelic Lab at Monash University.
Переглядів: 275
Відео
MARK CAMO - Urban Tribes Needle Park Cactus Nursery - APS Sydney - CACTUS DAY 2022
Переглядів 9212 роки тому
Mark Camo Urban Tribes Needle Park Cactus Nursery Owner-operator of one of the earliest entheogenic cactus gardens established in Australia, Mark talks about how this fascinating and diverse collection came to be, recalling his travels through Peru and South America during the 90s. Whilst there he not only collected specimens but participated in traditional Huachuma and Peyote ceremonies and he...
Psychedelic Harm Reduction | APS & Enlighten Mental Health
Переглядів 5562 роки тому
A Psychedelic Harm Reduction Webinar-Great for newbies!! In this webinar you will learn: -What psychedelic harm reduction is -Why harm reduction is an important part of the psychedelic journey -Tips and tools to effectively reduce risk in your own psychedelic experience This session was hosted by APS Vice President Antanika Hoberg, was facilitated by EMH CEO and Founder Eternity Hausen and clin...
The Origins of Cannabis Stigma by Daniel Roden
Переглядів 2793 роки тому
Daniel Roden is a student of Philosophy, Politics and Economics and is the current leader of SSDP UWA. Through his work with students and young activists, Daniel aims to help build the drug reform movement into a cohesive and informed community, capable of creating political and cultural change. Daniel is presenting on the history of cannabis stigma. Focusing on the beginnings of prohibition in...
Beyond Cannabis Prohibition; middle ground options for cannabis law reform and policy - Simon Lenton
Переглядів 2963 роки тому
Simon Lenton is Director of the National Drug Research Institute, where he has worked since 1993. In addition, he works part time as a clinical psychologist in private practice. Simon previously worked for the WA Alcohol and Drug Authority for 7 years, as clinical psychologist and manager. His research interests include bridging the gap between drug policy research and drug policy practice, ill...
Cannabis Neuropsychopharmacology by Moshe Meyers, PhD candidate,
Переглядів 1,8 тис.3 роки тому
Moshe Meyers is a Neuropsychopharmacologist Ph.D. Researcher at the University of Western Australia with interests in drug-assisted psychotherapy using psychedelics (psilocybin), entactogens (MDMA), and cannabis. This talk was part of The Perth Cannabis Conference 17-10-2021 which was a collaboration between APS and SSDP featuring a broad range of speakers discussing topics around cannabis in b...
Psychedelic Integration with Enlighten Mental Health
Переглядів 7763 роки тому
This psychedelic integration webinar was facilitated by Dr. Shevaugn Johnson from Enlighten Mental Health and hosted by APS. The webinar provided general information about integration and tips and tools for integrating a psychedelic experience. For further information please contact Enligthen Mental Health at www.enlightenmentalhealthaustralia.org
#MushroomDay21 - Interview with Dr. Monica Barratt
Переглядів 2103 роки тому
Nick Wallis interviews Dr. Monica Barratt (TWEET @monicabarratt) monicabarratt.net/ Monica currently works at RMIT University where she has been appointed as a Vice Chancellor’s Senior Research Fellow (2019-2023) at the Social and Global Studies Centre and the Digital Ethnography Research Centre. Monica continues her affiliations with the National Drug and Alcohol Research Centre, UNSW Sydney, ...
#MushroomDay21 - Psilocybin Research for Treating Nicotine Addiction
Переглядів 1633 роки тому
Interview conducted by Nick Wallis for 3CR's Enpsychedelia on 4th October 2015. www.3cr.org.au/enpsychedelia/episode-201510041400/ep14-magic-mushrooms-and-dr-albert-garcia-romeu Albert Garcia-Romeu, PhD Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Dr...
Rescheduling psilocybin and MDMA in Australia - A process explainer
Переглядів 7383 роки тому
There is a proposal before Australia's poisons, medicines and drug regulator, the TGA (Therapeutic Goods Administration) to down-schedule MDMA and psilocybin from Sch 9 to Sch 8, for use in limited therapeutic settings. The TGA will be considering their position (once more) in December 2021, following the September 30th tabling of an independent report. Nick Wallis from the Australian Psychedel...
Altered States: Tradition and Ritual
Переглядів 3773 роки тому
The return of psychedelics to academic and medical acceptability is the outcome of decades of work, and may signal a coming revolution for psychiatry. But as is often noted, similarly plant-based and consciousness altering substances have most likely been in use for thousands of years in a variety of Indigenous contexts. Uses in such contexts include (but are not limited to) medical application...
#MushroomDay21 - Psychedelic Australia with Dr. Martin Williams
Переглядів 7903 роки тому
Interview conducted by Jonathan Carmichael, co-founder and President of EGA. www.entheogenesis.org/ Find out more about EGA's December 2021 event, Garden States and purchase tickets here: www.gardenstates.org/ Martin Williams, PhD, is a research fellow in Medicinal Chemistry at the Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne. He is founding and current President of...
APS Perth - Altered States Series Workshop 4; Contemplative Practice with Chris Letheby
Переглядів 5593 роки тому
Dr. Chris Letheby - Psychedelics and Meditation: A Neurophilosophical Perspective (Altered States Seminar 4) Dr. Chris Letheby's presentation from the fourth seminar in the Perth Altered States Series explores the relationships between psychedelic experiences and contemplative practices such as mindfulness meditation. Dr Chris Letheby is a philosopher working on issues related to the therapeuti...
APS Perth - Altered States Series Workshop 4; Mindfulness & Psychedelics with Tobias Penno
Переглядів 4473 роки тому
APS Perth - Altered States Series Workshop 4; Mindfulness & Psychedelics with Tobias Penno
Trichocereus - A basic introduction by Tony Davey - APS Sydney - CACTUS DAY 2021
Переглядів 14 тис.3 роки тому
Trichocereus - A basic introduction by Tony Davey - APS Sydney - CACTUS DAY 2021
CACTUS DAY 2021: MIKE JAY in conversation with Jef Baker of The Australian Psychedelic Society
Переглядів 5943 роки тому
CACTUS DAY 2021: MIKE JAY in conversation with Jef Baker of The Australian Psychedelic Society
Melbourne Mushroom Day 2019 - Mushroom Cultivation 101 with Caine Barlow
Переглядів 2,2 тис.3 роки тому
Melbourne Mushroom Day 2019 - Mushroom Cultivation 101 with Caine Barlow
Melbourne Bicycle Day 2019 - Cam Duffy
Переглядів 1974 роки тому
Melbourne Bicycle Day 2019 - Cam Duffy
Melbourne Bicycle Day 2019 - Dr Prash Puspanathan
Переглядів 2084 роки тому
Melbourne Bicycle Day 2019 - Dr Prash Puspanathan
Melbourne Bicycle Day 2019 - Greg Kasarik
Переглядів 1234 роки тому
Melbourne Bicycle Day 2019 - Greg Kasarik
MIKE JAY on his book 'Mescaline: A Global History of The First Psychedelic' for APS' Cactus Day.
Переглядів 6314 роки тому
MIKE JAY on his book 'Mescaline: A Global History of The First Psychedelic' for APS' Cactus Day.
Mark Camo: Part1 Cactus botany and nursery tour. Part 2 Cactus Taxonomy, propagation and cultivation
Переглядів 4 тис.4 роки тому
Mark Camo: Part1 Cactus botany and nursery tour. Part 2 Cactus Taxonomy, propagation and cultivation
KUAUHTLI VASQUEZ: Peyote traditions and ceremony, interview for APS-Sydney Psychoactive Cactus Day
Переглядів 6 тис.4 роки тому
KUAUHTLI VASQUEZ: Peyote traditions and ceremony, interview for APS-Sydney Psychoactive Cactus Day
DR BRUCE DAMER : A Visionary Approach for Hope and Action in the Era of Climate Shock - APS Sydney
Переглядів 7634 роки тому
DR BRUCE DAMER : A Visionary Approach for Hope and Action in the Era of Climate Shock - APS Sydney
Chris Bache in conversation with Jef Baker - Australian Psychedelic Society Bicycle day 2020
Переглядів 1,6 тис.4 роки тому
Chris Bache in conversation with Jef Baker - Australian Psychedelic Society Bicycle day 2020
JAMES JESSO - Bad trips: rehabilitating after psychedelic turmoil - Australian Psychedelic Society
Переглядів 2,9 тис.4 роки тому
JAMES JESSO - Bad trips: rehabilitating after psychedelic turmoil - Australian Psychedelic Society
FROM SHOCK TO AWE - Panel discussion - Australian Psychedelic Society - Giant Dwarf Sydney 07/09/19
Переглядів 4184 роки тому
FROM SHOCK TO AWE - Panel discussion - Australian Psychedelic Society - Giant Dwarf Sydney 07/09/19
Bob Otis - Decriminalize Nature Oakland
Переглядів 1694 роки тому
Bob Otis - Decriminalize Nature Oakland
Symon Beck - Psilocybe Mushrooms of Australia - The Australian Psychedelic Society - Sydney
Переглядів 32 тис.4 роки тому
Symon Beck - Psilocybe Mushrooms of Australia - The Australian Psychedelic Society - Sydney
sup my junkies
Thank you!!!
TY SACRED CACTUS
Natives should gaurd this from others.
That rotating foot !! 🤮
I want to see a dialogue between Monica Gagliano and Charles Eisenstein.
Just found the channel & watched the video. Thankyou for sharing. What are some good websites that record what species people have found in certain locations? Thankyou :)
I’m such a green garden green thumb head 🚀
Does San Diego grow those 3???
Making tea now
But you know as far as the whole "there are holy righteous ways of getting high and "bad karma" ways of doing it, look it's the same thing I have said to the police and everyone else, I decide what I put in MY body, and fuck you if you don't like it, try and stop me
Will it save the endangered species if I uploaded a video showing a viable route to the drug from the whole list of natives it can be extracted from? It's very easy to make
You'd make a striking natural language model sir
Just so you know, I do need a daily amount of amphetamines to feel safe
Concise speaker. Appreciate Davids work.
Can Janes son claim he is of a religion that uses Mushrooms, and as the international human rights convention, says you cannot exclude anyone from any religion based on nationality or race, then he would be spiritually excluded from prosecution, incarceration and persecution? This would give him exemption based on his own religious beliefs, even if he starts his own religion with his mum, which cannot be prohibited.
We need to start a political party based on facts and not scare mongering. I am willing to be the sacrificial lamb, if I can get some financial backing and 500 members for state, and 2000 for national.
What a comprehensive and detailed guide! Thanks for sharing :)
You're very welcome!
f ur welcome to country off
Oak tree is majesty..
Love Monica. Her service and communion with plants is magnificent. Her work is now weaving through tech and numerous studies in plant communication and advanced consciousness. Mitákuye Oyás’iŋ Monica nee Anpoa Dowan. Da Naho 🪄🍃
Nice relaxing voices to take a nap to.
Good night
what is the barrier grit material called?
Zeolite. This mineral can come in multiple colors. Red, green and white to name a few.
Sincere appreciation for all your hard work team, excellent effort!
Thanks a ton
Thanks a lot guys I really enjoyed it….Gday from Geelong-dijillong
Our pleasure!
Great talk, I thoroughly enjoyed the knowledge, the fun, the wisdom, the connection to country, the straightforwardness and the immense respect for the plants...
Glad you enjoyed it!
What a legend
Agreed
Book, Sebastian, it's one micro-Kubrick overdue...
Yay Moni, That was wonderful😍
This is humbling and a beaut mate, thank you.
Such a guru!! Thanks for your expertise Symon!! ❤
That’s a lot of effort and organisation in order to trip balls
What's crazy also is how mushrooms play the businessmen between different trees, getting "paid" for shuttling nutrients from those which have to those which need. Read about "mother trees." P.S. even atoms respond to their environments. And all life is built from that "intelligence."
Anyone in Sydney's west want to take me out for a lesson in identifying?
That blew me away
What a wonderful talk. I am so with you Col.☮️🌵☮️
Please fix the audio.
If you prepare a PC for tea, is there a way to potentiate its efficacy by adding anything else?
Yeah mescaline
@@JeagerTv That certainly would have helped. The cultivar is not worth the effort I put it to it.
Thanks to all the panel members. Very interesting discussion. I am a peer worker in AOD (Alcohol and Other Drugs) and many drug users understand the therapeutic value of psychedelics, but I fear we will be last to be approved, because we are drug users
Wonderful to hear such intelligent concerns. I always felt that entheogenes were for people with healthy minds, but now on the contrary. Hopefully this leads into a legal stream of research and discovery. I often wonder about experimenting with age care, homeless, juvenile offenders, yes!! I’d go as far as a ´coming of age ritual’ in completion of high school. I’ve experienced 95% positive outcomes in personal, social and in experimental therapeutic healing retreats. Music, dancing, hugging, colour, 🌈meditation. A wish for more time to hold community and family pre and post integration with an even broader range of therapies available. Let’s develop ourselves where we look forward to fun in our old age, or for that matter, on the weekends and special occasions. I for one, have a list of names of very normal people who are quite happy to commit now in to eventually going into a ´holistic age retreat’, rather than a depressing ‘aged care home’ What’s to lose? fear ? All the experienced underground therapists and psychonaughts have a vital roll to share. I would suggest if not already, a visionary platform such as a Fb page or online seminars, where everyone agrees to respect and feel free to share their ideas with no barriers or backlash on their comments or careers. Healthy open discussions. How else to get started? Joining together to flourish the expansion of this wonderful opportunity for a mentally satisfied society with safe practices in place and hopefully some most suitable ‘ music playlists.🤞´ If we embrase different protocols and styles to suit all tastes and needs, aim to be perfect, and accept that there will be those occasional unsatisfactory outcomes as with any medicine. Let’s move ahead in a solid unified position at any given moment. Remember the German wall came down in a day.
Thanks very much for holding and posting this discussion. While I have been eagerly waiting this decision to treat CPTSD and treatment resistant depression, I also have concerns how this is going to be rolled out and who is going to provide appropriate training to the treatment professionals. Most psychiatrists work within a medical model and don’t deliver therapy, so I guess it is going to be a lot of hard work with lots of teething problems before we can really measure efficacy. The concern I have, is the patients (those with treatment resistant depression etc), are very vulnerable. I know myself, I have had so many bad experiences in the therapeutic environment without the addition of these medicines. Bad experiences in this context have the potential to do more damage than good, leaving the patent feeling helpless and hopeless. I guess it is going to be a lot of hard work nutting out models of care etc to ensure patients not left in a more vulnerable position. Lots of hard work ahead, but hopefully this will also weed out some of the cowboys currently using these substances without good models of care or even appropriate qualifications. I am eager, but I really hope we ‘get it right’ without doing more damage - both in models of treatment and outcomes for patients and for the overall public perception of the use of these substances as medicine. Lots of potential to ‘get it wrong’.
Great conversation! Very much appreciated the point about psychedelic-assisted therapy being done in a multi-disciplinary context. As well as social workers, mental health occupational therapists have an important perspective/role to play here as well. Thanks APS for facilitating and to all involved for their time.
Psilocybin has already been desceduled for therapeutic use in a number of states in the US. Legislation is being finalised now and there will soon be psychedelic assisted therapy centres opening in the state of Oregon. I think much can be learned from this roll-out. Their legalisation is attempting to ensure availability and accessibility for all who need treatment. I am also concerned that the approval in Australia did not follow the usual channels and loathe to think the reason is solely monetary rather than for the good of the Australian people. It has to be available for all who need it, not just the super rich.
Yeah $20,000 for synthetics sounds like a setup for a foreign corporation to make money from nature. if the individual isnt paying, the public is still paying. so a win win for them. It sounds like an obvious setup but that scam wont last long. the wave is happening.
Yes, I have to wonder if Mrs Rinehart and Mr Forest investments in associated ventures helped get the legislation 'over the line'. I think that it is a good thing that the Australian government are pursuing psychedelics as a treatment option (though this legislation) but as you say, I hope these treatments are available and accessible to everybody, not just those with deep pockets.
Forrest was behind the welfare card that sent people to suicide. Nobody talk about it. Trying to wipe their hands clean.
A very clear and sober session on where we stand at this present moment. I'm glad the concerns and tentative excitement seems to be the dominant feelings in the crowd. Well moderated too by Antanika.
Spot on Dr S Bright. I think anyone who is treating people with psychedelic need to experience the medicine. This will humble them and also get them out of there heads.
Not going to happen. The registration boards would de-register them
About time !
Let's gooo aussyyyy
After many decades of regressive suppression this is history in the making.
53:13. careful what we wish for. instead of therapy in nature, the cowboy corporate vultures will be patenting nature. They already have the formula for mdma and should be generics. Should be free and accessible to all. Should be made locally. Psy synthetics is not new has been used over the years and means it's controlled dosage, but no reason not to use natural.
There are many people who want to safely source an organic medicine before the storm... The problem is how and where to source? You have all tried these amazing medicines, however most of those who ask questions on how to source seriously with setting and sitters are answered with unfortunately is 'you can't ask that here'. What to do!?